The observed decrease in IL-22-producing ILC3s in Trmt61aΔRorc mice correlates with reduced TRMT61A expression levels, suggesting that similar mechanisms may operate in IBD, where inflammation could suppress TRMT61A expression, thereby diminishing ILC3 functionality. This evidence concerns the gene IL22 and inflammatory bowel disease.